Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;283(2):81-5.
doi: 10.1007/BF00371613.

Cytogenetic effects during extracorporeal photopheresis treatment of two patients with cutaneous T-cell lymphoma

Affiliations

Cytogenetic effects during extracorporeal photopheresis treatment of two patients with cutaneous T-cell lymphoma

U M Peterseim et al. Arch Dermatol Res. 1991.

Abstract

The effect of extracorporeal photopheresis (EP) on various cytogenetic parameters has been investigated. During EP the photoactivatable agent 8-methoxypsoralen (8-MOP) was administered orally. After 2 h a leukocyte-enriched blood fraction was collected by haemocentrifugation, irradiated with UVA extracorporeally, and reinfused to the patient. Two patients suffering from cutaneous T-cell lymphoma showed a marked clinical improvement in response to therapy. In order to investigate the cytogenetic effects and mutagenic risk of EP, the mitotic index (MI), the type and number of chromosomal aberrations and the rate of sister chromatid exchanges (SCE) were studied. Following EP treatment the patients' lymphocytes were cultured and stimulated with phytohaemagglutinin (PHA) for 48 or 72 h. The cultured lymphocytes showed a decreased MI after 48 h as an indicator of cytotoxic effects, but not after 72 h. In lymphocyte cultures not stimulated with PHA, the MI was decreased even after 72 h. The number of chromosomal aberrations and SCE were increased upon treatment, but only transiently, returning to basal levels between consecutive treatments. Our data provides no evidence for increased mutagenic risk as a consequence of effective EP treatment.

PubMed Disclaimer

Similar articles

Cited by

  • Extracorporeal Photopheresis-An Overview.
    Cho A, Jantschitsch C, Knobler R. Cho A, et al. Front Med (Lausanne). 2018 Aug 27;5:236. doi: 10.3389/fmed.2018.00236. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30211164 Free PMC article. Review.

References

    1. Br J Dermatol. 1977 Nov;97(5):519-28 - PubMed
    1. N Engl J Med. 1987 Feb 5;316(6):297-303 - PubMed
    1. Acta Derm Venereol Suppl (Stockh). 1982;106:1-42 - PubMed
    1. Hum Genet. 1982;60(1):19-23 - PubMed
    1. J Invest Dermatol. 1979 Jun;72(6):323-5 - PubMed

MeSH terms

LinkOut - more resources